SPY001 met its primary endpoint with a statistically significant reduction of 9.2 points (p<0.0001) from baseline at Week 12 in Robart’s ...

A company based in China voluntarily recalled several cough drop products, according to the FDA. Xiamen Kang Zhongyuan ...

The FDA has announced a voluntary recall of several cough drops and throat lozenges sold nationwide. Here are the brands ...

Spyre Therapeutics’ monoclonal antibody hit the key goal of a phase 2 study in ulcerative colitis (UC), which the company has touted as proof it can best Takeda’s Entyvio. The mid-stage trial ...

Analysts are intrigued by SPY001’s early efficacy and dosing convenience, noting that the drug could compete with therapies ...

KAI-7535, a once-daily injectable small-molecule GLP-1, will receive a $50 million boost following the IPO. Hengrui has ...

After a spectacular diving save by Jackson Fife that resulted in a BYU point Saturday night against USC, a post on social ...

Trial Combines LIXTE’s LB-100 with Dostarlimab; Results Give Patients New Hope for a Challenging Disease with Limited Therapeutic Options-BOCA ...

An upbeat personality has always followed Macy Lengacher. The 2023 NorthWood graduate and current Indiana State University ...

Volunteers reside in the park and are provided a full hook-up campsite while they serve. Volunteers are the primary point of ...

Spyre Therapeutics Inc. SYRE shares are up on Monday following the announcement of positive results from the Phase 2 SKYLINE ...

Spyre Therapeutics (NASDAQ:SYRE) shares climbed 25% on Monday after the company reported that its investigational therapy ...